Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue 
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions 
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025 
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal 
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy 
Dublin, Feb. 23, 2017 -- Research and Markets has announced the addition of the "Automated and Rapid Microbiological Tests - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Automated and Rapid Microbiological Tests in US$ Thousand by the following End-Use Segments:
Clinical Applications
- Automated Identification & Susceptibility Systems
- Automated Blood Culture Systems
- Automated Tuberculosis Systems
- Streptococcal Infection Rapid Tests
- GC/Chlamydia Rapid Tests
- Other Automated & Rapid Microbiological Tests
Non-Clinical Applications.
The report profiles 83 companies including many key and niche players such as
- Abbott Laboratories (US)
- Abbott Molecular, Inc. (US)
- Alere Inc. (US)
- Beckman Coulter, Inc. (US)
- Becton Dickinson and Company (US)
- bioMérieux SA (France)
- bioMerieux, Inc. (US)
- Bio-Rad Laboratories, Inc (US)
- Cellabs Pty Ltd (Australia)
- Cepheid Inc. (US)
- CorisBioconcept SPRL (Belgium)
- F. Hoffmann-La Roche AG (Switzerland)
- Hologic, Inc. (US)
- MedMira Inc. (Canada)
- Meridian Bioscience, Inc. (US)
- OraSure Technologies, Inc. (US)
- Orion Diagnostica Oy (Finland)
- QIAGEN N.V. (The Netherlands)
- Quidel Corporation (US)
- Sekisui Diagnostics, LLC (US)
- Siemens Healthcare GmbH (Germany)
- Thermo Fisher Scientific Inc. (US)
- Oxoid Limited (UK)
Key Topics Covered:
1. Industry Overview
2. Competition
3. Market Drivers And Trends
4. Key Issues Confronting The Rapid Microbiological Tests Market
5. Product/Technology Overview
6. Application Areas Of Automated And Rapid Microbiological Tests A Review
7. Product Innovations/Introductions
8. Recent Industry Activity
9. Focus On Select Global Players
10. Global Market Perspective
Total Companies Profiled: 83 (including Divisions/Subsidiaries - 90)
- The United States (55)
- Canada (1)
- Japan (4)
- Europe (27)
- France (3)
- Germany (9)
- The United Kingdom (3)
- Italy (2)
- Spain (1)
- Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (2)
- Middle East (1)
For more information about this report visit http://www.researchandmarkets.com/research/2m732j/automated_and
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology
